Showing 3,461 - 3,480 results of 18,392 for search 'significant ((((((a decrease) OR (we decrease))) OR (teer decrease))) OR (mean decrease))', query time: 0.61s Refine Results
  1. 3461

    Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

    Published 2025
    “…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
  2. 3462
  3. 3463
  4. 3464
  5. 3465

    Integration of Metabolomics, Transcriptomics, and 16s rRNA Sequencing Reveals the Mechanism of Morus alba <i>L.</i> (Sangzhi) Alkaloids (SZ-A) in Improving Cholesterol Metabolism i... by Caina Li (4126462)

    Published 2025
    “…The results showed that repeated treatment with 200 mg/kg SZ-A significantly decreased the total cholesterol and low-density lipoprotein cholesterol levels in the blood and increased the fecal content of two conjugated bile acids, taurodeoxycholic acid (TDCA) and taurolithocholic acid (TLCA). …”
  6. 3466

    DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  7. 3467

    DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  8. 3468

    DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  9. 3469

    DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  10. 3470

    Table 1_Concurrent enhancement of provitamin A and yield in tropical maize hybrids.docx by Abebe Menkir (4511086)

    Published 2025
    “…Results showed a significant annual increase of 2.05% in provitamin A and 3.54% in β-carotene, alongside a 1.09% reduction in β-cryptoxanthin. …”
  11. 3471
  12. 3472
  13. 3473
  14. 3474

    Data Sheet 1_Lack of association between genetic variations in CYP3A5 and blood pressure or hypertension risk in the UK biobank.pdf by Pia Leibold (21390134)

    Published 2025
    “…While some previous studies reported that CYP3A5 variants were associated with decreased blood pressure and risk of HTN, others reported no associations. …”
  15. 3475
  16. 3476
  17. 3477

    Data Sheet 1_Isoform-specific vs. pan-histone deacetylase inhibition as approaches for countering glioblastoma: an in vitro study.docx by Ameya Joshi (1290186)

    Published 2025
    “…</p>Methods<p>In the present study, we used a rotary cell culture technique to culture 3D cancer spheroids of the T98G cell line. …”
  18. 3478
  19. 3479

    Juvenile demyelination impairs the maturation of PV interneurons in the PFC. by Sara Hijazi (21656615)

    Published 2025
    “…Average action potential (AP) frequency in response to 0-650 pA current steps illustrating a significant decrease in PV interneuron firing frequency in cuprizone-treated mice. …”
  20. 3480